QA: ALIMERA SCIENCES INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2023_ALIMERA_SCIENCES_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001267602, ALIMERA SCIENCES INC

  xvar xval
0 AssetsCurrent 29,413,000
1 IntangibleAssetsNetIncludingGoodwill 8,957,000
2 PropertyPlantAndEquipmentNet 2,525,000
3 remainder_Assets 1,707,000
4 LiabilitiesCurrent 39,732,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,871,000
9 ResearchAndDevelopmentExpense 16,228,000
10 remainder_Expenses 42,579,000
11 remainder_Revenues 54,129,000
12 remainder_NetIncome -558,000
13 remainder_ComprehensiveNetIncome -1,106,000
  yvar yval
0 Assets 42,602,000
1 Liabilities 39,732,000
2 Expenses 71,678,000
3 Revenues 54,129,000
4 StockholdersEquity 2,870,000
5 NetIncome -18,107,000
6 ComprehensiveNetIncome -18,660,000
7 BaseVar 104,902,500
8 EconomicCapitalRatio -0.333

Edgar->Model Mapping

Feature Distribution

Change over Time